Ilya Pharma CEO in interviewed by LifeScience Sweden
Special thanks to the author PhD student Vilhelmiina Haavisto, ETH Zurich, for the very well written piece and the interesting folklore history of Angels Glowing, nature is fantastic, especially when bioluminescent and when engineering is possible to utilise the already existing properties in new ways for the benefit of people.
Beyondbiotech August episode 11, Rounding up news of the week and interviewing interesting companies - Yes also Ilya Pharma - please hear our CEO Evelina Vågesjö and CFO Oskar Lund give an update and share some details around the latests patents approved - at 29:50 to 43:00.
Cell and gene therapies are taking off in a big way in Europe. As the buzz grows, the Swedish firm Ilya Pharma has raised €8.5M to lay down the foundations of bacterial gene therapies for enterocolitis and diabetic ulcers.
Therapeutic concepts, work and science being recognised for significant contributions in the advanced therapy pipeline in the MedicineMakers PowerList 2021.
The team also published an expert opinion on the mechanism of actions explored and progress of pipeline in 2019 in Öhnstedt et al., Expert Opinion on Drug Discovery 2019;14(5):485-497.